Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “In Situ Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07067437
What this trial is testing

Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)

Who this might be right for
Breast Neoplasms
National Institute of Oncology, Hungary 250
Not applicableStudy completedNCT03061175
What this trial is testing

Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy

Who this might be right for
Stage 0 Breast CancerStage I Breast CancerStage IA Breast Cancer+5 more
Rutgers, The State University of New Jersey 94
Not applicableStudy completedNCT00874458
What this trial is testing

MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Centre Antoine Lacassagne 40
Not applicableNot Yet RecruitingNCT07492043
What this trial is testing

Breast Tumour Size Measurement by Field Cycling Imaging

Who this might be right for
Breast CancerDuctal Carcinoma In Situ
University of Aberdeen 12
Early research (Phase 1)Study completedNCT03323658
What this trial is testing

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Ductal Carcinoma In Situ+2 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Looking for participantsNCT06218303
What this trial is testing

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Who this might be right for
Ductal Carcinoma in Situ
Finn, Olivera, PhD 50
Early research (Phase 1)Study completedNCT00107211
What this trial is testing

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 30
Testing effectiveness (Phase 2)Study completedNCT02150525
What this trial is testing

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Who this might be right for
Ductal Breast Carcinoma in SituBreast Cancer, Stage IBreast Cancer, Stage II+1 more
Ohio State University Comprehensive Cancer Center 52
Not applicableStudy completedNCT06106282
What this trial is testing

Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more
Mayo Clinic 105
Large-scale testing (Phase 3)Study completedNCT00281658
What this trial is testing

Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 444
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Testing effectiveness (Phase 2)Study completedNCT00334542
What this trial is testing

Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Not applicableStudy completedNCT00569166
What this trial is testing

Three Different Programs of Paced Breathing in Treating Hot Flashes in Women

Who this might be right for
Breast CancerFatigueHot Flashes+1 more
Mayo Clinic 105
Not applicableStudy completedNCT04999826
What this trial is testing

Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+19 more
Mayo Clinic 105
Not applicableStudy completedNCT01052740
What this trial is testing

X-Ray Mammography Standard of Care Protocol

Who this might be right for
Breast CancerInvasive CarcinomaIn Situ Carcinoma+2 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT03789097
What this trial is testing

Vaccination With Flt3L, Radiation, and Poly-ICLC

Who this might be right for
Non-Hodgkin's LymphomaMetastatic Breast CancerHead and Neck Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 17
Early research (Phase 1)Active Not RecruitingNCT05340673
What this trial is testing

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast Carcinoma
City of Hope Medical Center 208
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Not applicableLooking for participantsNCT06984250
What this trial is testing

Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer

Who this might be right for
Early Breast CancerDuctal Breast Carcinoma In Situ
National Taiwan University Hospital 315
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Next Page